510(k) Report

510(k) · Cleared

Recalled · Class II · 2013

Interlink S / Clearlink System / V-Link Lad with Vitalshield Protective Coating Non-Dehp Catheter Extension Set Kits,

K103551510(k) TraditionalCleared Mar 25, 2011113-day reviewClass II21 CFR 880.5440Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baxter Healthcare Corp · FPA Set, Administration, Intravascular

Cleared on Mar 25, 2011 as substantially equivalent to K861557 (Aplicare, Inc., 1986) and 3 other predicates after a 113-day review. Its family tree reaches back 4 generations to 1992. It has been recalled once.

Decided
Mar 25, 2011
Review
113 days
Class
Class II
Product code
FPA
Recalls
1
Predicates
4

Its longest line of descent runs back 4 generations to K915571 (1992). 7 ancestors in all, the oldest K861557 (1986). No later device cites it as a predicate yet.

  1. Root · 4 generations backK915571 Clave ConnectorIcu Medical, Inc. · 1992 · Recalled
  2. 3 generations backK973916 NP Medical Capless Luer Activated ValveNp Medical, Inc. · 1998
  3. 2 generations backK072576 Clearlink Antimicrobial Luer Activated Device (Lad) and Extension…Baxter Healthcare Corp · 2007
  4. 1 generation backK081289 V-Link Antimicrobial Luer Activated Device and Extension Sets with…Baxter Healthcare Corp · 2008
  5. This deviceK103551 Interlink S / Clearlink System / V-Link Lad with Vitalshield…Baxter Healthcare Corp · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K915571Clave ConnectorIcu Medical, Inc.19923
−3K973916NP Medical Capless Luer Activated ValveNp Medical, Inc.1998—
−2K072576Clearlink Antimicrobial Luer Activated Device (Lad) and Extension Sets with…Baxter Healthcare Corp2007—
−1K081289V-Link Antimicrobial Luer Activated Device and Extension Sets with V-Link…Baxter Healthcare Corp2008—
0 (this device)K103551Interlink S / Clearlink System / V-Link Lad with Vitalshield Protective…Baxter Healthcare Corp2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199510
200010
FIG. 1 — Lineage of K103551, 1992–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K861557Aplicare Skin Protectant Prep Pad
Summary page 2
…880.5090, Product Code NEC), PREDICATE DEVICES: Table 5-2. Previous 510(k)s Device Company Previous Clearance date 510(k) APLICARE Skin Protectant Prep Pad APLICARE, | K861557 July 11, 1986 Modified Interlink Injection Site Septum July 18, 1993 Healthcare Modification to Solution Administration Set | Bax…
Aplicare, Inc.1986—
*K003225Solution Administration Sets with Capless Luer Activated Valve
Summary page 2
…tectant Prep Pad APLICARE, | K861557 July 11, 1986 Modified Interlink Injection Site Septum July 18, 1993 Healthcare Modification to Solution Administration Set | Baxter K003225 October 19, 2000 with Capped Luer Activated Device Healthcare (Clearlink). , CLEARLINK Antimicrobial Luer Activated | Baxter K072…
Baxter Healthcare Corp200018
*K072576Clearlink Antimicrobial Luer Activated Device (Lad) and Extension Sets with the…
Summary page 2
…Solution Administration Set | Baxter K003225 October 19, 2000 with Capped Luer Activated Device Healthcare (Clearlink). , CLEARLINK Antimicrobial Luer Activated | Baxter K072576 November 6, 2007 Device and Extension Sets with Healthcare CLEARLINK Antimicrobial Luer Activated Device V-LINK Antimicrobial Lue…
Baxter Healthcare Corp2007—
*K081289V-Link Antimicrobial Luer Activated Device and Extension Sets with V-Link Antimicrobial…
Summary page 2
…ated | Baxter K072576 November 6, 2007 Device and Extension Sets with Healthcare CLEARLINK Antimicrobial Luer Activated Device V-LINK Antimicrobial Luer Activated Baxter K081289 August 4, 2008 Device and Extension Sets with V-LINK Healthcare Antimicrobial Luer Activated Device Traditional 5…
Baxter Healthcare Corp2008—
*—Modified Interlink Injection Site Septum
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 28, 2013Class IIZ-1270-2013Packaging process controlCustomers have reported that when separating an individual package from its attached grouping, the adjacent package has opened, compromising its sterile barrier properties.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 5.5 years on median.
  • 3 of the 7 ancestors have a recall of any class.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The IV extension tubing kits provide the user with a “ready-to-use” set up for the administration and withdrawal of fluids avoiding the need to acquire/assemble components from various manufacturers. The kits are indicated for one-time use.

The IV extension tubing set is indicated for use with a vascular access device for administration and withdrawal of fluids.

The Vital-Hold catheter stabilization device and the foam tape strips are indicated to provide a method for catheter securement.

The APLICARE skin prep pad is indicated to prepare the skin prior to application of a dressing or bandage.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K103551: Interlink S / Clearlink System / V-Link Lad with Vitalshield Protective Coating Non-Dehp Catheter Extension Set Kits,.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103551

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026